Montelucast
Sodium
Presentation by
Primary Information Services
www.primaryinfo.com
mailto:primaryinfo@gmail.com
Source: https://drugsdetails.com/montelukast/
2.The montelukast sodium market
is segmented based on product type,
dosage form and region. Based on
product type this market is segmented
into montelukast sodium amorphous and
montelukast sodium crystalline. Further,
based on dosage form this market is
segmented into tablets, chewable
tablets and oral solutions.
1.Manufacturers
• Morepen Laboratories
• Mylan
• TAPI
• MSN Laboratories
• Ultratech
• Aurobindo Pharma
3.Montelukast Sodium Market size is forecast to reach $856 million by 2025, growing at
a CAGR of 7.2% during the forecast period 2020-2025.
Montelukast Sodium is used to treat asthma and seasonal year-round allergies. An
increasing number of asthma patients and increasing prevalence of seasonal allergies
also known as seasonal allergic rhinitis or hay fever are the major factors driving the
growth of the market. The rise in respiratory diseases coupled with the growing
geriatric population is set to further enhance the overall market demand of Montelukast
Sodium during the forecast period 2020-2025.
Market Scenario
Database Contents on offer
Questions?
Email
!

Montelucast sodium

  • 1.
    Montelucast Sodium Presentation by Primary InformationServices www.primaryinfo.com mailto:primaryinfo@gmail.com
  • 4.
  • 7.
    2.The montelukast sodiummarket is segmented based on product type, dosage form and region. Based on product type this market is segmented into montelukast sodium amorphous and montelukast sodium crystalline. Further, based on dosage form this market is segmented into tablets, chewable tablets and oral solutions. 1.Manufacturers • Morepen Laboratories • Mylan • TAPI • MSN Laboratories • Ultratech • Aurobindo Pharma 3.Montelukast Sodium Market size is forecast to reach $856 million by 2025, growing at a CAGR of 7.2% during the forecast period 2020-2025. Montelukast Sodium is used to treat asthma and seasonal year-round allergies. An increasing number of asthma patients and increasing prevalence of seasonal allergies also known as seasonal allergic rhinitis or hay fever are the major factors driving the growth of the market. The rise in respiratory diseases coupled with the growing geriatric population is set to further enhance the overall market demand of Montelukast Sodium during the forecast period 2020-2025. Market Scenario
  • 9.
  • 10.